PSEN2 and keratoconjunctivitis: The topical Co(III) chelate CTC-96 has been demonstrated to reduce the severity of conjunctival viral infection and make its resolution faster in the in vivo model of keratoconjunctivitis consisting of rabbits infected with the Adenovirus type 5 (ad-5) and to have virucidal and antiviral activity against ad-5-infected HeLa, A549, and SIRC cell lines [10].